Buscar
01/10/2025
Brachio-cervical inflammatory myopathy: evidence for a distinct form of inflammatory muscle disease
Kleefeld, F, Vigo, EG, Gamboa, JT, Funke, A, Roos, A, Mensch, A, Gehrig, J, Ruck, T, Mossakowski, A, Llanso, L, Bortolani, S, Torchia, E, Casal-Dominguez, M, Pinal-Fernandez, I, Mammen, A, Tasca, G, Preusse, C, Stenzel, W. Brachio-cervical inflammatory myopathy: evidence for a distinct form of inflammatory muscle disease. NEUROMUSCULAR DISORDERS. 2025; 53DOI:10.1016/j.nmd.2025.105458. PMID:. IF:2.800(Q2/5D).
01/09/2025
Monitoring Patients with Relapsing-Remitting Multiple Sclerosis Switching from Intravenous to Subcutaneous Natalizumab every 4 Weeks vs every 6 Weeks
Moreno, AA, Presas-Rodríguez, S, Gonzalez-Garcia, AM, Teniente-Sera, A, Martínez-Cáceres, EM, Querol, L, Martín-Aguilar, L, Meca-Lallana, JE, Dos Santos, CE, Millán, J, López, GV, Orgaz, ATC, Ruiz, VC, Anunciación, BAJ, Hervas, JV, Ruiz, LB, Bravo, GCA, Ramo, C. Monitoring Patients with Relapsing-Remitting Multiple Sclerosis Switching from Intravenous to Subcutaneous Natalizumab every 4 Weeks vs every 6 Weeks. Multiple Sclerosis Journal. 2025; 31(3)DOI:. PMID:. IF:5.000(Q1/2D).
01/09/2025
Cracking the code: genotype-phenotype correlation models in sarcoglycanopathies
Luce, L, Kocak, G, Alonso-Pérez, J, Straub,, Töpf, A, Díaz-Manera, J. Cracking the code: genotype-phenotype correlation models in sarcoglycanopathies. NEUROMUSCULAR DISORDERS. 2025; 53DOI:. PMID:. IF:2.800(Q2/5D).
01/09/2025
Denervated human muscle fibers promote reinnervation via neurotrophic factor release in SMA and ALS
Gokul-Nath, R, Collins, C, Valverde, L, Lleixa, C, Verdu-Diaz, J, Di Lorenzo, A, Llarch, P, Querol, L, Marini-Bettolo, C, Rojas-Garcia, R, Diaz-Manera, J. Denervated human muscle fibers promote reinnervation via neurotrophic factor release in SMA and ALS. NEUROMUSCULAR DISORDERS. 2025; 53DOI:10.1016/j.nmd.2025.105462. PMID:. IF:2.800(Q2/5D).